Cardiac transplantation and other therapeutic options in the treatment of end-stage heart disease

Comprehensive Therapy

Volumn 26, Issue 2, 2000, Pages 109-113

  Dabol, R ^a   Edwards, N M ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DEVICE; DONOR; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; ORGAN PRESERVATION; SURGICAL TECHNIQUE; XENOTRANSPLANTATION;

EID: 0033866673     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-000-0020-y     Document Type: Article

References (22)

1. The Stanford experience: Survival and renal function in the pre-Sandimmune era compared to the Sandimmune era
2. Longterm effects of cyclosporin-based immunosuppression in cardiac transplantation: The Loyola experience
3. Evaluating the donor pool: Impact of using hearts from donors over the age of 49 years
4. Tailored therapy before transplantation for treatment of advanced heart failure: Effective use of vasodilators and diuretics
5. Outpatient dobutamine for refractory congestive heart failure: Advantages, techniques, and results
6. Interleukin-2 receptor blockade with daclizumab to prevent acute rejection in renal transplantation: Daclizumab Triple Therapy Study Group
7. Regulation by differential development of Th-1 and Th-2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion
8. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody
9. Pathologic features in long-term cardiac allografts
10. The use of HMG-CoA reductase inhibitors to prevent accelerated graft atherosclerosis in heart transplant patients
11. The continuing evolution of mechanical ventricular assistance
12. Implantable left ventricular assist devices: An evolving long-term cardiac replacement therapy
13. Heterotransplantation of the kidney: Two clinical experiences
14. Recent advances and the potential for clinical use of xenotransplantation
15. Cardiac xenotransplantation
16. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: Preliminary results
17. Early results of transmyocardial revascularization with a holmium laser
18. Neovascularization occurs at the site of closed laser channels after transmyocardial laser revascularization
19. Clinical outcome after left ventricular surgical remodeling in patients with idiopathic dilated cardiomyopathy referred for heart transplantation: Short-term results
20. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor
21. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in ischemic porcine heart